India, Sept. 12 -- image credit- pib

The Indian Pharmacopoeia Commission (IPC), an autonomous body under the Ministry of Health and Family Welfare, Government of India, recently organised a two-day national conference on "Quality and Safety of Biosimilars: Strengthening India's Biopharma Shakti (SHAKTI) Vision" at the Centre for Cellular and Molecular Platforms (C-CAMP), Bengaluru.

A major highlight of the conference was the release of the Indian Pharmacopoeia Reference Substance (IPR) for Enoxaparin Sodium for Bioassays. Enoxaparin Sodium is a low molecular weight heparin and anticoagulant widely used for the prevention and treatment of thromboembolic disorders.

The IPR for Enoxaparin Sodium for Bioassays can serve as a certified refe...